Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Schizophrenia Research |
| Vol/bind | 228 |
| Sider (fra-til) | 190-192 |
| Antal sider | 3 |
| ISSN | 0920-9964 |
| DOI |
|
| Status | Udgivet - feb. 2021 |
Bibliografisk note
Funding Information:
Funding/support: The work was supported by Vestfold Hospital Trust, Division of Mental Illness and Drug Addiction, the Research Council of Norway (#223273, #283798), South East Health Authority (#2016025, #2019108,), the Josef and Haldis Andresen's foundation (#15/145518/HTR), Torgeir Lindvig's Trust (#2013). We would also like to thank the staff at EPHAPS and NORMENT for their part in recruiting participants and collecting data, all the participants for their time and effort, as well as Erikka Grose-Demuth for editing the manuscript.
ID: 285882991